CELU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Celularity Inc (CELU) is not a strong buy at this moment for a beginner investor with a long-term focus. The stock exhibits weak technical indicators, negative financial performance trends, and lacks significant positive catalysts to justify immediate investment. Holding off for now is a prudent decision.
The stock is currently in a bearish trend. The MACD histogram is negative and expanding, RSI indicates oversold conditions at 16.229, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.145 and resistance at 1.34.
Celularity recently closed a $13.3 million transaction with NexGel to monetize biomaterials and improve its capital structure. Additionally, it secured a strategic licensing deal worth up to $35 million.
The company received a Nasdaq compliance notice for delayed filing of its Form 10-K, threatening its listing status. Financial performance has been weak, with significant revenue declines and gross margin deterioration.
In 2025/Q3, revenue dropped by -43.16% YoY to $5.28 million, gross margin fell by -64.94% YoY to 19, while net income improved slightly but remains negative at -$23.08 million. EPS increased to -0.88, up 20.55% YoY.
No recent analyst ratings or price target changes are available for CELU.
